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3. RESULTS OF HUMAN EXPERIMENTS 
 
 We are confronted with a two-tiered regulatory system: first, effects occur at a local level 
during direct contact of maternal and fetal cells in the placenta, principally through cellular 
contacts; secondly, effects occur on the whole maternal immune system. We had planned to 
conduct our research in two areas: first investigating the immunological mechanisms in the 
periphery analyzing peripheral blood mononuclear cells (PBMC) obtained from heparanized 
venous blood. The other part of the work focused on the local immunological regulatory 
mechanisms directly investigated in placental samples (decidua and trophoblast).  
 
3.1. Investigating the immunological mechanisms of implantation failure after in vitro 
fertilization (IVF) 
 
In the first part, we started the work on human models investigating the immunological 
mechanisms in the periphery during implantation in in vitro fertilization (IVF) patients. Assisted 
reproductive techniques are now routine gynecological procedures. Although their efficiency is 
undoubted, a notable proportion of IVF cycles result in failed conception resulting in emotional 
and financial strain for the couples. Much effort has been made to predict IVF treatment 
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outcome and characterize IVF patients’ chances prior to the procedure. A major field of interest 
is immune profile analysis of IVF candidates since unexplained female infertility, as well as 
recurrent spontaneous abortion and implantation failure, are thought to be associated with 
pathological maternal immunotolerance mechanisms. 
19 women undergoing IVF treatment cycles were investigated. All women in both 
groups received the same hormonal supplementation. IVF cycles were successful in 8 patients 
(sIVF), defined by positive blood β-HCG test performed on the first and third week after 
embryo transfer followed by live birth at term. The failed IVF group (fIVF) was defined by the 
negative blood β-HCG tests performed on both the first and the third week after embryo transfer 
(11 women). 
 
Patients’ demographic, gynecological and treatment characteristics. (Table I.) 
 Successful IVF 
(sIVF) 
Failed IVF 
(fIVF) 
P-value 
No. of patients 8 11  
Age (years) (mean) 36,87 35,18 NS 
Tubal factor (%) 27,27 22,5 NS 
Male factor (%) 45,45 62,5 NS 
Other (%) 27,27 25 NS 
Duration of infertility (years) (mean) 6,06 4,95 NS 
Basal FSH levels (IU/ml) 7,63 6,29 NS 
Mean no. of previous failed IVF 
attempts 
2,37 1,45 NS 
Mean no. of previous miscarriages 0 0 NS 
No. of oocytes collected (mean) 6,6 9,63 NS 
No. of available embryos for IVF 
(mean) 
4,62 4,45 NS 
No. of available embryos for transfer 
(mean) 
2,87 2,45 NS 
Gestational age at birth (mean) 36,75 weeks - - 
Birth weight (mean) 3060 g - - 
Number of live birth / number of 
embryos transferred 
8/23 0/24 - 
Live birth/ patients 8/8 0/11 P<0.05 
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In summary of that work, we focused on the immunprofile analysis of IVF candidates. 
Previous studies on peripheral NK cell characteristics of IVF patients were limited to the 
comparison of blood samples taken prior to the IVF procedure.  
In our study we analyzed IVF patient’s data from a different point of view. Besides 
separating successful IVF patients from patients with failed conception, we performed a follow-
up study and compared patients’ data on the day of the oocyte retrieval with the data one week 
after embryo transfer. 
We found different changes of NK and NKT-like cell characteristics in this interval in 
pregnant women and in non pregnant women. At the second time of investigation (one week 
after IVF) women with failed IVF showed elevated peripheral NK (both CD56bright and 
CD56dim) and NKT-like cell ratios, increased perforin containing CD56bright cells, more 
activated and degranulated NKdim cells and enhanced NK cell activating receptor (CD160, 
NKG2D) expression  on both cell types as well as on both NK cells subsets (Table II. and III.). 
 
Natural killer cell phenotype characteristics in women with successful conception and in 
women with failed IVF. (Table II.) 
 
 Successful IVF  
(sIVF) 
 Failed IVF 
(fIVF) 
 
 Before IVF After 
IVF 
P-
value 
Before IVF After 
IVF 
P-
value 
No. of patients 8  11  
CD3-CD56+ cells 11,09±3,16 11,01±2,8 NS 5,28±0,74 9,66±1,11 0,002 
CD56bright 1,41±0,42 1,67±0,56 NS 0,47±0,07 1,26±0,39 0,04 
CD56dim 9,94±2,85 9,61±2,38 NS 4,88±0,73 8,53±0,88 0,001 
CD 160 expression by  
CD3-CD56+ cells 
26,31±4,43 24,68±5,69 NS 20,43±3,38 27,71±2,88 0,03 
CD56bright  9,58±1,64 10,22±3,49 NS 6,51±1,52 14,9±3,35 0,01 
CD56dim  28,14±4,69 26,04±6,11 NS 21,25±3,51 28,61±2,84 0,05 
NKG2D expression by 
 CD3-CD56+ cells 
73,7±9,12 69,93±8,6 NS 50,14±8,35 71,64±9,28 0,01 
CD56bright 84,66±3,63 78,01±6,81 NS 73,1±7,51 79,91±7,15 0,03 
CD56dim 71,77±9,38 68,27±9,07 NS 47,81±8,16 70,71±9,38 0,01 
 
We assume that one of the crucial points in failed IVF treatment is the significant 
increase in NK cells from the date of oocyte collection to the time one week after embryo 
transfer in the same individual. All these findings in the fIVF group reflect unfavorable, Th1 
oriented changes of NK and NKT-like cells during this short period of time around IVF 
procedure. Comparing the follow-up data of pregnant women they remain principally constant.   
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Natural killer cell functional characteristics in women with successful conception and in 
women with failed IVF. (Table III.) 
 
 
 Successful IVF  
(sIVF) 
 Failed IVF 
(fIVF) 
 
 Before IVF After  
IVF 
P-
value 
Before IVF After  
IVF 
P-
value 
No. of patients 8 - 11 - 
Perforin expression by CD3-
CD56+ cells 
52,54±6,53 50,05±4,96 NS 55,59±4,16 57,51±3,23 NS 
       CD56bright 16,75±3,92 18,51±5,21 NS 15,29±5,24 24,34±5,49 0,02 
       CD56dim  55,51±7,02 52,41±5,25 NS 58,44±4,08 60±3,34 NS 
No. of patients 7 - 9 - 
CD107a expression by CD3-
CD56+cells 
15,69±2,6 15,27±3,8 NS 12,48±2,23 15,94±2,57 0,02 
       CD56bright 8,73±2,85 10,03±2,48 NS 12,97±2,96 13,95±3,85 NS 
       CD56dim  16,73±2,64 15,68±3,96 NS 12,01±2,49 15,92±2,52 0,02 
 
Previous studies on peripheral NK cell characteristics of IVF patients were limited to the 
comparison of pregnant and non pregnant patients’ data from one blood sample prior to the IVF 
procedure. Here we demonstrate that changes of NK and NKT-like cell phenotype during the 
implantation window and early pregnancy in the same individual may also be important for 
successful embryo implantation. 
 
 
3.2. Investigating the expression of PACAP in the human placenta and its possible effect 
on the survival of choriocarcinoma cells 
 
We have also continued good progress investigating different regulatory effects of a 
neuropeptide thought to play a role in reproductive functions, such as pregnancy. Pituitary 
adenylate cyclase activating polypeptide (PACAP), a neuropeptide with survival-promoting 
actions, has been shown in endocrine organs and is thought to play a role during pregnancy. In 
the present study, we determined the concentrations of PACAP in first trimester and full-term 
human placentas using radioimmunoassay. 
We found high levels of PACAP38 and lower levels of PACAP27 in different parts of 
the full-term human placenta. PACAP38 content increased in the placenta during pregnancy, 
both on the maternal and the fetal side (Fig. 1.). 
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Fig 1. PACAP38 and PACAP27 concentrations as measured by RIA in different parts of 
the mature human placenta and umbilical cord. 
 
Choriocarcinoma cells have been previously shown to have functional receptors for 
PACAP and to react with increased cAMP levels upon PACAP treatment. The effects of 
PACAP on the survival of human choriocarcinoma cells was investigated using flow cytometry 
and MTT cell viability asssay in cells exposed to the widely-used chemotherapeutic agent, 
methotrexate. It was found that PACAP neither influenced the survival of cytotrophoblast cells 
nor affected the cellular response to the death-inducing effect of the chemotherapeutic agent 
methotrexate (Fig. 2.).  
 
 
 
Fig. 2. Viability of JAR human choriocarcinoma cells as measured by MTT assay. 
 
The present observations further support the significance of PACAP in the human 
placenta. The observation that PACAP did not influence the effects of methotrexate may have 
future clinical importance, showing that PACAP does not decrease the effects of certain 
chemotherapeutic agents. 
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3.3. Analysis of the expression profiles of peripheral CD160+ lymphocytes during the 
course of healthy human pregnancy  
 
In our other paper published in the American Journal of Reproductive Immunology, we 
investigated the phenotype of peripheral CD160+ cells during healthy pregnancy. 
Sixty-one pregnant women at different stages of pregnancy without any risk factors and 
12 age-matched non pregnant healthy women were included in this study. In order to analyze 
the whole course of healthy pregnancy we divided the 40 gestational weeks into 4 stages: into 3 
trimesters as routinely and additionally we defined the last 4 gestational weeks as “late 
pregnancy” (Table IV). 
 
Comparison of patients’ characteristics (Table IV.) 
 
Groups 
 
 
Non-
pregnant 
 
1st 
trimester 
    
2nd 
trimester 
  
3rd 
trimester 
 
Late 
pregnancy 
 
Significance 
 
Age (year) 
 
 
31.00 ±3.09 
 
32.12 ±3.22 
     
26,63 ±2.05 
 
28.36 ±1.17 
    
31,25 ±1.77 
 
NS * 
 
Gestational age 
(weeks) 
 
 
- 
 
8.4 (6-12) 
 
16.1 (16-17) 
 
26.7 (25-29) 
 
38.6 (37-41) 
 
- 
 
No. of patients 
(n) 
 
 
12 
 
22 
 
12 
 
17 
 
10 
 
- 
 
CD160 is one of the NK cell receptors which could deliver activating signals regulating 
cytotoxicity and cytokine production. During this work we investigated the systemic CD160 
receptor expression profile providing new data about the nature of CD160+ lymphocytes at 
different stages of normal pregnancy. 
Studying the peripheral blood of healthy pregnant and non-pregnant women we found 
that CD160 receptor is present on peripheral lymphocytes during the whole course of gestation 
(Fig. 3a.). During the course of pregnancy CD160+ lymphocytes showed a significant increase 
of the early T cell activation marker (CD69) expression in the 3rd trimester which was followed 
by a significant fall in the late pregnancy stage (Fig. 3b.). Our data revealed that peripheral 
CD160 receptor could be functional rather in the 3rd trimester than in other stages. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. a). The expression of CD160 NK cell activating receptor by peripheral blood lymphocytes  
of healthy pregnant and non-pregnant women. b).Presence of CD69 activation marker on CD160+ and CD160– 
lymphocytes of healthy pregnant and non-pregnant women. 
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We also analyzed two other NK cell receptors on peripheral blood lymphocytes (PBLs): 
the NK cell activating NKG2D receptor and the NK cell inhibitory NKG2A one. While NKG2A 
expression (Fig. 4a.) was constant throughout pregnancy, NKG2D showed a strong significant 
decrease in the 1st trimester followed by a significant increase in the 2nd trimester (Fig. 4b.). It 
could be possible that NKG2D receptor activation is useful during the sentinel function of NK 
or γ/δ T cells in the latter stages of healthy pregnancy, for example against infectious agents. 
NKG2A inhibitory receptor on PBLs showed a constantly low expression in all patient groups 
investigated.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. The expression of NKG2A NK cell inhibitory and NKG2D activating receptor by peripheral blood 
lymphocytes of healthy pregnant and non-pregnant women. 
 
Furthermore, in our study we described some basic characteristics of CD160 expressing 
lymphocytes which are independent from pregnancy or its stage. Accordingly, peripheral 
CD160+ cells show a high NK activating (Fig. 5a.) and inhibitory (Fig. 5b.) receptor expression, 
an elevated activation rate and Vδ2+ T cells have a special character to express CD160 receptor. 
The NKG2D and the NKG2A profile of CD160+ lymphocytes showed a strong significant fall 
during the period of implantation compared to non pregnant group, which suggests that other 
receptor functions could be involved in the control of CD160+ cells during that time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. The expression of activating NKG2D and inhibitory NKG2A NK cell receptor on peripheral 
CD160+ lymphocytes during the course of healthy pregnancy. 
 
In the 2nd trimester, 20% of peripheral CD160+ cells express TCR γ/δ, which are mostly 
Vδ2+, suggesting that Vδ2 receptor could be of interest on CD160+ lymphocytes (Fig. 6a.). 
There is a low percent of CD160+ cells which are Vδ2 TCR+ during implantation followed by 
an apparent but not significant augmentation in the 2nd trimester (Fig. 6b.). Moreover, in the 2nd 
trimester more than 65% of Vδ2+ T cells bear CD160 receptor conserving this high expression 
level until the end of pregnancy. It suggests that this γ/δ T lymphocyte population could have 
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immunological significance in CD160 receptor function from that time on. This hypothesis is 
supported by our observation that only 19% of Vδ2-negative lymphocytes express CD160 in the 
2nd trimester and there are no biologically relevant changes in other stages.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Gamma/delta TCR expression on CD160+ peripheral blood lymphocytes during the course of pregnancy.  
 
Our results revealed that CD160+ cells could be able to produce pro-inflammatory 
cytokines which could play a part in the controlled sterile inflammatory response characterizing 
normal human gestation assisting the maintenance of healthy pregnancy. 
 
3.4. Phenotypic characterization of decidual haematopoietic progenitor cells in first 
trimester in healthy pregnant women and in women with early miscarriage.  
 
In our paper forthcoming in American Journal of Reproductive Immunology, we 
demonstrated the presence of haematopoietic progenitor cells (HPC) in first trimester human 
deciduas. Decidual lymphocytes play a major role in the recognition of the semi-allogenic fetus 
creating a favorable environment for implantation, placentation and for the early development of 
the fetus. This recognition of fetal HLA antigens presented by the extravillous trophoblast leads 
to the control of trophoblast invasion. Abnormal implantation is associated with many 
pregnancy related disorders. Little is known about the homing, proliferation and differentiation 
of decidual lymphocytes. Besides being recruited from the periphery, local (extrathymic) 
lymphocyte development is also conceivable. 
Eight pregnant women with early (7–12 weeks) miscarriage of unexplained etiology 
(mean age of 34.87 ± 1.76 range, 30-45 years) were recruited to participate in the study and 
served as a pathological pregnant group. For a relevant control group, we selected 16 healthy 
women who underwent elective terminations of apparently normal pregnancies at the 6-10 
weeks of gestation. Neither had a history of spontaneous abortion, ectopic pregnancy, preterm 
delivery, or stillbirth. The mean age of these women was 34.69 ± 2.62 (range, 24-47) years. 
Direct evidence for the presence of heamatopoietic progenitor cells in the adult 
endometrium was obtained by flow cytometric phenotypic analysis of isolated endometrial 
lymphocytes by Lynch et. al.. HPCs were identified by their co-expression of CD34 and the 
leukocyte marker CD45. 
Identification of decidual HPC commitment was based on the expression of 
differentiation markers on CD34+CD45+ cells. CD7 receptor is an early marker for lymphoid 
HPC development including both T cell and NK cell differentiation potential. CD122 receptor is 
essential for NKT cell 17 and CD127 for γ/δ T cells development. 
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Haematopoietic progenitor cells were identified by their co-expression of CD34 and the 
leukocyte marker CD45 by flow cytometric analysis in all decidual samples of both healthy 
pregnant women (0.44%) and in patients with miscarriage (0.48%) (Fig. 7.). Compared to 
peripheral blood, we found a significant increase in the percentage of decidual HPCs within the 
lymphogate in both healthy pregnant women and women with spontaneous abortion (0.03 vs 
0.44, p<0.02 and 0.01 vs. 0.48, p<0.01 respectively) (Fig. 7.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.  Phenotypic detection of haematopoietic progenitor cells in peripheral blood and in the decidua 
 
C-kit (CD117) is a cytokine receptor for the cytokine stem cell factor (CSF) and it is 
expressed on the surface of the HPC in the early phase of differentiation. C-kit expression of 
CD34+CD45+ HPCs was lower in the decidua compared to the periphery in both investigated 
groups but the difference did not reach the level of statistical significance (Fig. 8A.). 
For the analysis of activation and differentiation potential of HPCs we determined the 
expression of CD45RA on CD34+CD45+ HPCs. In healthy pregnant women there is a 
significant decrease (36.81 vs 58.73, p<0.01) in CD45RA expressing HPCs in the decidua when 
compared to the periphery (Fig. 8B). There was no significant difference in the expression of 
CD117 and CD45RA by HPCs in the decidua between healthy and pathologic pregnant women. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8.  CD117 (c-kit) and CD45RA expression by CD34+CD45+ HPCs 
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Henceforward, we focused on the lymphoid differentiation markers since decidual 
lymphocytes play a crucial role in the maintenance of early pregnancy. 
T/NK progenitor cells were identified by their expression of CD7 on CD34+CD45+ 
cells. Among decidual HPCs, T/NK precursor levels are significantly increased in the decidua 
compared to peripheral blood in both healthy and pathologic pregnancy (Fig. 9A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9.  The expression of CD7 and CD56 by CD34+CD45+ HPCs in the decidua and in matched blood of healthy 
pregnant and pathological pregnant women. 
 
Both in the healthy pregnant and in the pathologic pregnant group, there are significantly 
higher decidual CD56+CD34+CD45+ NK progenitor populations than in the peripheral blood 
(Fig. 9B.; healthy pregnant: 34.48 vs. 7.41, p<0.001; pathologic pregnant: 54.00 vs. 6.15, 
p<0.001). Furthermore, among HPCs in women with spontaneous abortion, there is a 
significantly larger NK progenitor cell population in the decidua compared with healthy 
pregnancy (Fig. 9B and 4D; 54.00 vs. 34.48, p<0.002) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10.  The expression of CD122 and CD127 by CD34+CD45+ HPCs in the decidua and in matched blood of 
healthy pregnant and pathological pregnant women. 
 
NKT progenitors (CD122+CD34+CD45+ HPCs) and γ/δ T cell progenitors 
(CD127+CD34+CD45+ co-expression) were present in the decidua and their occurrence shows 
similar distribution as seen in the periphery in both donor group (NKT progenitors: Fig. 10C, 
12.86 vs. 24.14 and 5.51 vs.7.85; γ/δ T cell progenitors: Fig 10D. 2.05 vs. 5.43 and 1.06 vs. 
4,94). 
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In this work we demonstrated the presence of HPCs in first trimester deciduas. Apart 
from a small proportion of immature, c-kit expressing HPCs the majority of decidual 
haematopoietic progenitor cells appear to be already committed to lineage specific proliferation. 
Here we demonstrated the decidual presence of the T/NK, NK, NKT and γ/δ T cell 
progenitors suggesting local autonomous self-support of the decidual lymphocyte pool. 
Additionally, the decidual lineage-committed lymphoid cell population shows a similar 
distribution profile to mature decidual lymphocytes, suggesting they may arise locally. 
Compared to peripheral blood, the ratio of the T/NK precursor cells and NK precursors among 
decidual HPCs is significantly higher in the decidua. The observations that both precursor cell 
types, the less committed T/NK progenitors and the more differentiated NK progenitor cells are 
enriched in the decidua strongly suggest that the dominance of uterine NK cells is ensured from 
the beginning of local lymphocyte development. 
In this study we identified decidual HPCs in women with early spontaneous abortion and 
the levels of decidual CD56+ progenitor cells among HPCs was found to be significantly higher 
compared to their levels in decidual samples of healthy pregnant women. These data suggest a 
dysregulation of decidual HPC maturation resulting in an increased density of NK cells at the 
feto-maternal interface. High numbers of decidual NK cells may at least partly account for 
disturbances in the immunological recognition of the fetus which is strongly related to the 
success of implantation and placentation via different effector functions, such as cytokine 
production. HPC dysregulation may pose a new target area for reproductive immunotherapeutic 
approaches, such as the treatment of infertility or habitual abortions and the practical 
significance of local decidual haematopoiesis will further increase. 
 
4. RESULTS OF ANIMAL EXPERIMENTS 
 
Animal models are important, as they allow for controlled experiments and analysis of 
multiple time-points during pregnancy. 
 The mouse gene family of TIM molecules includes 8 members (encoding TIM-1, TIM-2, 
TIM-3 and TIM-4 proteins and the putative TIM-5 to TIM-8 proteins), while the human gene 
family includes 3 members encoding TIM-1, TIM-3 and TIM-4 proteins. 
 TIM-3 was the first, and is presently the only, surface molecule that can specifically 
identify Th1 cells in both mice and humans. Engagement of TIM-3 by its ligand galectin-9 
negatively regulates IFN-γ secretion and influences the ability to induce T cell tolerance in both 
mice and humans. 
 Analyzing lymphocytes from healthy pregnant mice by flow cytometry, we found an 
elevated TIM-3 expression on different cell populations (CD8, CD4, γ/δ T cells) in the decidua 
compared to peripheral splenocytes. 
Galectin-9 (the ligand for TIM-3) expression by spongiotrophoblast was successfully 
detected at the feto-maternal site of mouse (Balb/c mice) placenta by immuno-histochemistry.  
Since we could detect galectin-9 expression by healthy mouse placentae, we analyzed the 
gene expression of galectin-9 by real-time RT-PCR during healthy pregnancy investigating 
healthy placentae and fetal resorptions. In fetal resorptions examined during mid-pregnancy, 
galectin-9 expression is 4-times lower compared to healthy mouse placentae, suggesting the role 
of TIM-3/galectin-9 pathway in the pathomechanism of pathologic pregnancies.  
